Free Trial

Cipher Pharmaceuticals (CPH) Competitors

Cipher Pharmaceuticals logo
C$12.91 +0.13 (+1.02%)
As of 03:59 PM Eastern

CPH vs. THCX, CRON, GUD, TLRY, ACB, WEED, FIRE, OGI, EPI, and ICC

Should you be buying Cipher Pharmaceuticals stock or one of its competitors? The main competitors of Cipher Pharmaceuticals include Hydropothecary (THCX), Cronos Group (CRON), Knight Therapeutics (GUD), Tilray Brands (TLRY), Aurora Cannabis (ACB), Canopy Growth (WEED), Supreme Cannabis (FIRE), Organigram (OGI), ESSA Pharma (EPI), and ICC Labs (ICC). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Cipher Pharmaceuticals vs. Its Competitors

Cipher Pharmaceuticals (TSE:CPH) and Hydropothecary (CVE:THCX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.

Cipher Pharmaceuticals has a net margin of 59.92% compared to Hydropothecary's net margin of 0.00%. Cipher Pharmaceuticals' return on equity of 17.93% beat Hydropothecary's return on equity.

Company Net Margins Return on Equity Return on Assets
Cipher Pharmaceuticals59.92% 17.93% 7.90%
Hydropothecary N/A N/A N/A

1.4% of Cipher Pharmaceuticals shares are owned by institutional investors. 42.0% of Cipher Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cipher Pharmaceuticals presently has a consensus target price of C$14.75, indicating a potential upside of 14.25%. Given Cipher Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Cipher Pharmaceuticals is more favorable than Hydropothecary.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cipher Pharmaceuticals
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.75
Hydropothecary
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Cipher Pharmaceuticals has higher revenue and earnings than Hydropothecary.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cipher PharmaceuticalsC$19.03M12.18C$11.41MC$0.9114.26
HydropothecaryN/AN/AN/AN/AN/A

In the previous week, Cipher Pharmaceuticals had 1 more articles in the media than Hydropothecary. MarketBeat recorded 1 mentions for Cipher Pharmaceuticals and 0 mentions for Hydropothecary. Cipher Pharmaceuticals' average media sentiment score of 0.00 equaled Hydropothecary'saverage media sentiment score.

Company Overall Sentiment
Cipher Pharmaceuticals Neutral
Hydropothecary Neutral

Summary

Cipher Pharmaceuticals beats Hydropothecary on 11 of the 11 factors compared between the two stocks.

Get Cipher Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CPH vs. The Competition

MetricCipher PharmaceuticalsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$231.78MC$2.16BC$5.50BC$6.27B
Dividend YieldN/A2.92%4.25%6.72%
P/E Ratio14.264.1528.1053.96
Price / Sales12.18577.05402.281,133.24
Price / Cash3.5310.3535.5383.29
Price / Book3.2611.248.264.99
Net IncomeC$11.41MC$21.15BC$3.24BC$301.20M
7 Day Performance-1.53%0.18%0.50%0.74%
1 Month Performance-1.97%4.36%7.99%4.39%
1 Year Performance54.98%3.03%28.68%25.18%

Cipher Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CPH
Cipher Pharmaceuticals
1.0365 of 5 stars
C$12.91
+1.0%
C$14.75
+14.3%
+53.8%C$231.78MC$19.03M14.265News Coverage
THCX
Hydropothecary
N/AC$5.30
+6.6%
N/A+0.0%C$949.11MN/A0.00N/AHigh Trading Volume
CRON
Cronos Group
N/AC$2.84
+1.8%
N/A-16.9%C$749.94MC$76.86M-15.80450
GUD
Knight Therapeutics
0.9987 of 5 stars
C$6.08
+0.7%
C$7.15
+17.6%
+4.7%C$614.99MC$348.70M-20.30725
TLRY
Tilray Brands
N/AC$0.79
+14.5%
N/A-69.1%C$509.05MC$610.34M-1.912,650
ACB
Aurora Cannabis
0.7367 of 5 stars
C$6.21
+2.6%
C$8.75
+40.9%
-27.5%C$339.74MC$195.83M-7.671,073
WEED
Canopy Growth
1.5254 of 5 stars
C$1.69
+1.8%
C$2.20
+30.2%
-84.9%C$271.87MC$519.68M-0.252,700News Coverage
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29M-10.97400News Coverage
OGI
Organigram
2.5434 of 5 stars
C$1.93
+1.6%
C$3.33
+72.3%
-16.0%C$238.44MC$180.58M-4.08987
EPI
ESSA Pharma
N/AC$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725
ICC
ICC Labs
N/AC$1.62
-5.8%
N/A+0.0%C$223.64MC$533.68K95.29N/AGap Up

Related Companies and Tools


This page (TSE:CPH) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners